Fel-O-Vax IV (Canada)

Manufacturer: Wyeth Animal Health

Feline Rhinotracheitis-calici-panleukopenia-chlamydia Psittaci Vaccine

Killed Virus and Chlamydia

Fel-O-Vax IV Indications

For the vaccination of healthy cats 8 to 10 weeks of age or older as an aid in the prevention of disease caused by feline rhinotracheitis, calici, panleukopenia viruses and Chlamydia psittaci.

Dose

Inject one 1 mL dose subcutaneously using aseptic technique. Repeat in 3 to 4 weeks. Annual revaccination with a single dose of vaccine is recommended.

Fel-O-Vax IV Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.

U.S. Patent Nos. 5,242,686 - 6,004,563

For Veterinary Use Only

Manufactured by Fort Dodge Animal Health, Fort Dodge, Iowa 50501 U.S.A.

U.S. Vet. License No. 112

Trademarks used under license

Distributed in Canada by Wyeth Animal Health, Division of Wyeth Canada, Guelph, Ontario, Canada

10 mL	10 Doses	C2203F
50 x 1 mL	50 Doses	C2202I

Nac No.

11570605